News

You are here

INJECT-ID
Novosanis receives grant from Interreg CrossCare to build a next-generation of its unique and patented intradermal drug delivery device, VAX-ID, in collaboration with living labs Happy...
VAX-ID intradermal drug delivery device
Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September...
Novosanis will present its VAX-ID™ device platform during BioJapan
"High Frequency Ultrasound to Assess Skin Thickness in Healthy Adults” published in the prestigious peer-reviewed journal VACCINE.

Pages